AzurRx BioPharma, Inc.
USD3.45
+0.07 (+2.07%)
CEO
James Sapirstein
IPO Date
2016-10-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.38
Prev. Close
$3.38
Day Low
$3.38
Day High
$3.66
52W Low
$2.68
52W High
$26.30
Market Cap
$0.00B
Volume
0.63M
| 0 |
| $0.00 |
| 9 Jul 2021 | Pennington James | CHIEF MEDICAL OFFICER | A-Award | Acquired | 100,000 | $0.75 |
| 2 Jul 2021 | Schneiderman Daniel H | CHIEF FINANCIAL OFFICER | A-Award | Acquired | 250,000 | $0.85 |
| 2 Jul 2021 | Schneiderman Daniel H | CHIEF FINANCIAL OFFICER | A-Award | Acquired | 35,006 | $0.85 |
| 2 Jul 2021 | Schneiderman Daniel H | CHIEF FINANCIAL OFFICER | J-Other | Disposed | 250,000 | $0.85 |
| 2 Jul 2021 | SAPIRSTEIN JAMES | director, officer: PRES, CEO & CHAIRMAN OF BOARD | A-Award | Acquired | 900,000 | $0.85 |
| 2 Jul 2021 | SAPIRSTEIN JAMES | director, officer: PRES, CEO & CHAIRMAN OF BOARD | J-Other | Disposed | 900,000 | $0.85 |
| 6 Jan 2021 | BORKOWSKI EDWARD | director | A-Award | Acquired | 41,237 | $0.97 |
| 6 Jan 2021 | Oakes Gregory | director | A-Award | Acquired | 41,237 | $0.97 |